LABCORP HOLDINGS INC.·4

Feb 13, 12:48 PM ET

Davis Jeffrey A. 4

4 · LABCORP HOLDINGS INC. · Filed Feb 13, 2026

Research Summary

AI-generated summary of this filing

Updated

Labcorp (LH) Director Jeffrey A. Davis Converts 897 RSUs

What Happened

  • Jeffrey A. Davis, a director of Labcorp Holdings Inc. (LH), had 897 restricted stock units (RSUs) vest and convert into 897 shares on February 11, 2026. The Form 4 shows 897 shares acquired via conversion (derivative code M) and 897 shares disposed with a reported price of $0.00.
  • The filing indicates the RSUs vested fully on February 11, 2026 (footnote F2). The pair of entries (acquired and disposed for the same number of shares) results in no net increase in reported beneficial ownership.

Key Details

  • Transaction date: February 11, 2026; Form 4 filed February 13, 2026 (appears timely).
  • Transaction type: Exercise/conversion of derivative (code M) — RSU vesting and conversion to stock.
  • Shares acquired: 897 (price listed as N/A on the acquisition line).
  • Shares disposed: 897 at $0.00 (reported as a derivative disposition).
  • Net change in ownership: 0 shares (897 acquired and 897 disposed).
  • Footnotes: F1 = each RSU converts to one share; F2 = RSUs vested fully on Feb 11, 2026; F3 = the number reported reflects the aggregate RSUs held by the reporting person.
  • No cash sale or open-market purchase is reported; the $0.00 disposal is consistent with company retention/withholding practices (e.g., to satisfy taxes), though the filing does not state the exact mechanism.

Context

  • This is a routine conversion of vested RSUs rather than a market buy or sell that signals trading intent. When RSUs vest, companies commonly withhold or retain a portion (or all) of the shares to cover tax withholding; the equal acquire-and-dispose entries here are consistent with that practice.
  • Derivative code M covers exercises or conversions — in this case the conversion of RSUs into common stock. The filing shows no proceeds from a sale, and no indication of a 10% owner or a 10b5-1 plan.

Insider Transaction Report

Form 4
Period: 2026-02-11
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-11+8975,460 total
  • Exercise/Conversion

    Restricted Stock Unit

    [F1][F2][F3]
    2026-02-11897773 total
    Common Stock (897 underlying)
Footnotes (3)
  • [F1]Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
  • [F2]The Restricted Stock Units vested fully on February 11, 2026.
  • [F3]This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
Signature
/s/ Kathryn W. Kyle, Attorney-in-Fact for Jeffrey A. Davis|2026-02-13

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT